|

Ixazomib (NINLARO®) capsules / Matching placebo capsules Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Queen Mary University of London1

Indications

  • Secondary Progressive Multiple Sclerosis1
  • Primary Progressive Multiple Sclerosis1
  • Relapsing Remitting Multiple Sclerosis1
  • Multiple Sclerosis1

Other1 trial

SIZOMUS Safety of Ixazomib Targeting Plasma Cells in Multiple Sclerosis
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.